202 related articles for article (PubMed ID: 2542020)
1. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.
Crook T; Morgenstern JP; Crawford L; Banks L
EMBO J; 1989 Feb; 8(2):513-9. PubMed ID: 2542020
[TBL] [Abstract][Full Text] [Related]
2. Loss of HPV-16 E7 dependence in cells transformed by HPV-16 E7 plus EJ-ras correlates with increased c-myc expression.
Pim D; Banks L
Oncogene; 1991 Apr; 6(4):589-94. PubMed ID: 2030911
[TBL] [Abstract][Full Text] [Related]
3. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
Lees E; Osborn K; Banks L; Crawford L
J Gen Virol; 1990 Jan; 71 ( Pt 1)():183-93. PubMed ID: 2154535
[TBL] [Abstract][Full Text] [Related]
4. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.
Peacock JW; Benchimol S
EMBO J; 1994 Mar; 13(5):1084-92. PubMed ID: 8131742
[TBL] [Abstract][Full Text] [Related]
6. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
Liu Z; Ghai J; Ostrow RS; Faras AJ
Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias.
Fujinaga Y; Okazawa K; Nishikawa A; Yamakawa Y; Fukushima M; Kato I; Fujinaga K
Virus Genes; 1994 Sep; 9(1):85-92. PubMed ID: 7871765
[TBL] [Abstract][Full Text] [Related]
9. Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.
Belaguli NS; Pater MM; Pater A
J Med Virol; 1995 Dec; 47(4):445-53. PubMed ID: 8636718
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
11. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
12. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
13. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
[TBL] [Abstract][Full Text] [Related]
14. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Belcastro M; Miller MR; Flynn DC; Soisson AP
Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human papillomavirus type 16 polypeptides in transformed primary cells.
Banks L; Crawford L
Virology; 1988 Jul; 165(1):326-8. PubMed ID: 2838970
[TBL] [Abstract][Full Text] [Related]
16. HPV-16 E7 functions at the G1 to S phase transition in the cell cycle.
Banks L; Barnett SC; Crook T
Oncogene; 1990 Jun; 5(6):833-7. PubMed ID: 2359620
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-dependent transformation by human papillomavirus type 16 E7 coding and 3' noncoding sequences.
Pater A; Belaguli NS; Gardner HA; Mithal A; Pater MM
Virology; 1992 May; 188(1):369-72. PubMed ID: 1314461
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
